PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-03-19

Date Title Company
19-Mar-2025 FIRST EVER PATIENT DOSED WITH ALPIBECTIR-ETHIONAMIDE IN COMBINATION WITH FIRST-LINE TB DRUGS IN A 14-DAY PHASE 2 CLINICAL TRIAL BioVersys AG